Cellectar Biosciences' PIPE - III Round

Cellectar Biosciences raised a round of funding on April 15, 2011. Investors include Wisconsin Investment Partners.

Cellectar Therapeutics, formerly Novelos Therapeutics, is a radiopharmaceuticals company that designs and develops products to detect, treat and monitor a wide variety of human cancers. Cellectar's no…

Articles about Cellectar Biosciences' PIPE - III Round: